全文获取类型
收费全文 | 32781篇 |
免费 | 3028篇 |
国内免费 | 612篇 |
专业分类
耳鼻咽喉 | 394篇 |
儿科学 | 693篇 |
妇产科学 | 467篇 |
基础医学 | 2088篇 |
口腔科学 | 540篇 |
临床医学 | 2405篇 |
内科学 | 3254篇 |
皮肤病学 | 232篇 |
神经病学 | 1176篇 |
特种医学 | 1243篇 |
外国民族医学 | 45篇 |
外科学 | 3281篇 |
综合类 | 4198篇 |
预防医学 | 2639篇 |
眼科学 | 420篇 |
药学 | 1765篇 |
17篇 | |
中国医学 | 690篇 |
肿瘤学 | 10874篇 |
出版年
2024年 | 52篇 |
2023年 | 561篇 |
2022年 | 1323篇 |
2021年 | 1564篇 |
2020年 | 1387篇 |
2019年 | 1271篇 |
2018年 | 1279篇 |
2017年 | 1197篇 |
2016年 | 1315篇 |
2015年 | 1275篇 |
2014年 | 2334篇 |
2013年 | 2314篇 |
2012年 | 2015篇 |
2011年 | 2200篇 |
2010年 | 1844篇 |
2009年 | 1739篇 |
2008年 | 1566篇 |
2007年 | 1675篇 |
2006年 | 1481篇 |
2005年 | 1202篇 |
2004年 | 1004篇 |
2003年 | 818篇 |
2002年 | 695篇 |
2001年 | 592篇 |
2000年 | 547篇 |
1999年 | 466篇 |
1998年 | 371篇 |
1997年 | 310篇 |
1996年 | 289篇 |
1995年 | 225篇 |
1994年 | 199篇 |
1993年 | 150篇 |
1992年 | 146篇 |
1991年 | 123篇 |
1990年 | 99篇 |
1989年 | 98篇 |
1988年 | 114篇 |
1987年 | 71篇 |
1986年 | 52篇 |
1985年 | 95篇 |
1984年 | 62篇 |
1983年 | 47篇 |
1982年 | 58篇 |
1981年 | 27篇 |
1980年 | 43篇 |
1979年 | 32篇 |
1978年 | 26篇 |
1977年 | 23篇 |
1976年 | 10篇 |
1974年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
21.
Palat Balachandran M.S. M.Ch. Shaleen Agarwal M.S. M.Ch. Narendra Krishnani M.D. Chandra M. Pandey Ph.D. Ashok Kumar M.S. M.Ch. Sadiq S. Sikora M.S. Rajan Saxena M.S. Vinay K. Kapoor M.S. 《Journal of gastrointestinal surgery》2006,10(6):848-854
The aim of this study was to examine the predictors of long-term survival (>24 months) in patients with gall bladder cancer.
A retrospective review of 117 cases of gall bladder cancer resected between 1989 and 2000. The resections included 80 simple
cholecystectomies and 37 extended procedures. Patients with survival >24 months (n=44) were compared with those having survival
<24 months (n=73) for 17 prognostic factors. Overall median survival was 16 months with a 5-year survival of 27%. T status
(P=.000) and adjuvant chemoradiotherapy (P=.001) were independent predictors of long-term survival. Survival advantage was
seen in T3N+ve disease (P=.007) with extended procedures. Complete (R0) resection was attained in 30 patients with a 5-year
survival advantage of 30% as compared with incomplete (R1) resection (P=.0002). Adjuvant chemoradiotherapy improved survival
in simple cholecystectomy group (P=.0008) but no advantage was seen after extended procedures. Stage III (P=.001) and node-positive
disease (P=.0005) had significant benefit with adjuvant therapy. Poor differentiation and vascular invasion were associated
with poor long-term survival. R0 resection was associated with prolonged survival. Extended procedures improved survival in
patients with T3N+ve disease. Addition of chemoradiotherapy made significant improvement in long-term survival in stage III
and node-positive lesions and in patients undergoing simple cholecystectomy. R0 resection predicted long-term survival in
gall bladder cancer. T3 N+ve disease had better survival after extended procedures. Adjuvant chemoradiotherapy improved survival
in stage III and node-positive disease. Poor differentiation and vascular invasion were adverse predictors of survival. 相似文献
22.
The aim of our study was to determine the incidence, timing, and severity of vaginal stenosis in patients with carcinoma of the cervix who had received pelvic and/or vaginal radiotherapy as part of their treatment. We also sought to determine if there were any predisposing factors for the development of stenosis. A retrospective chart review was undertaken for all the patients diagnosed with carcinoma of the cervix between January 1, 1990, and December 31, 2000 and treated with pelvic and/or vaginal radiation at Westmead Hospital. Since January 1, 1990, data regarding vaginal stenosis has been prospectively recorded on all the patients. Data collected included patient demographics, stage of disease, treatments administered, and incidence, timing, and severity of vaginal stenosis. One hundred and eighty-eight patients were treated. Mean age was 58.6 years. Thirteen percent of patients had stage IB disease, 45% had stage II disease, 39.5% had stage III disease, and 1.5% had stage IV disease. One hundred and seventy-nine patients returned for follow-up, and data regarding vaginal toxicity were available in 98%. Twenty-seven percent had grade 1 toxicity (partial stenosis or shortening but not complete occlusion), and 11% had grade 2 (complete occlusion). Stenosis of any grade was noted at a mean of 9.6 months and median of 7.5 months (range, 26 days-5.6 years) from completion of treatment. The only prognostic factor associated with increased risk of stenosis was age greater than 50 years (odds ratio 2.26). Vaginal stenosis is a common complication of pelvic and vaginal radiotherapy, occurring in 38% of patients. Stenosis occurs most often in the first year after treatment. Patients over the age of 50 are most at risk. 相似文献
23.
Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of hemoglobin levels
K. Münstedt P. Johnson M.K. Bohlmann M. Zygmunt R. von Georgi† & H. Vahrson 《International journal of gynecological cancer》2005,15(2):285-291
Anemia has been associated with a poorer treatment response and reduced survival in women undergoing primary radiotherapy (RT) or radiochemotherapy for advanced cervical carcinoma. This study aimed to determine the influence of anemia on outcome in patients with cervical carcinoma undergoing adjuvant RT. Medical records were reviewed for 183 cervical cancer patients who had received adjuvant RT because of risk factors after radical surgery (n= 109) or inadequate primary surgery (simple hysterectomy; n= 74). Kaplan-Meier and Cox regression analyses were used to study hemoglobin levels before and during adjuvant RT in relation to recurrence-free and overall survival. Hemoglobin values > or =11 g/dL were considered normal, while those <11 g/dL indicated anemia. Hemoglobin levels before RT influenced significantly overall survival and recurrence-free survival across the whole group (overall survival--log rank(all patients)= 7.5; df = 1; P= 0.006). However, subgroup analysis showed that the observed difference was mainly due to the group of women who had undergone inadequate primary surgery (overall survival--log rank(inadequate surgery)= 10.8; df = 1; P= 0.001). Multifactorial regression analyses comparing hemoglobin before RT with grading and tumor stage confirmed the prognostic value of hemoglobin values. Maintaining normal hemoglobin values before and during adjuvant RT seems to be important, especially in patients who have had inappropriate simple hysterectomy, which may resemble a therapeutic situation. 相似文献
24.
P Sundaresan R Yeghiaian-Alvandi V Gebski 《Journal of Medical Imaging and Radiation Oncology》2010,54(1):69-75
Palliative whole brain radiotherapy (WBRT) is often recommended in the management of multiple brain metastases. Allowing for WBRT waiting time, duration of the WBRT course and time to clinical response, it may take 6 weeks from the point of initial assessment for a benefit from WBRT to manifest. Patients who die within 6 weeks (‘early death’) may not benefit from WBRT and may instead experience a decline in quality of life. This study aimed to develop a prognostic index (PI) that identifies the subset of patients with lung cancer with multiple brain metastases who may not benefit from WBRT because of ‘early death’. The medical records of patients with lung cancer who had WBRT recommended for multiple brain metastases over a 10-year period were retrospectively reviewed. Patients were classified as either having died within 6 weeks or having lived beyond 6 weeks. Potential prognostic indicators were evaluated for correlation with ‘early death’. A PI was constructed by modelling the survival classification to determine the contribution of these factors towards shortened survival. Of the 275 patients recommended WBRT, 64 (23.22%) died within 6 weeks. The main prognostic factor predicting early death was Eastern Cooperative Oncology Group (ECOG) status >2. Patients with a high PI score (>13) were at higher risk of ‘early death’. Twenty-three per cent of patients died prior to benefit from WBRT. ECOG status was the most predictive for ‘early death’. Other factors may also contribute towards a poor outcome. With further refinement and validation, the PI could be a valuable clinical decision tool. 相似文献
25.
尼莫地平联合卡维地洛治疗原发性高血压78例临床分析 总被引:1,自引:0,他引:1
目的分析尼莫地平联合卡维地洛治疗原发性高血压的临床疗效。方法将150例原发性高血压随机分成两组,对照组给予尼莫地平治疗,治疗组在对照组治疗的基础上,加之卡维地洛。结果治疗组与对照组显效率分别为33.3%和26.4%,总有效率为88.5%和76.4%,两组相比具有显著性差异(P〈0.05)。结论尼莫地平联合卡维地洛治疗原发性高血压疗效更为显著。 相似文献
26.
脾切除治疗原发性骨髓纤维化适应证的探讨 总被引:1,自引:0,他引:1
目的:探讨脾切除治疗原发性骨髓纤维化的可行性及其效果。方法:回顾性分析我院2000年1月至2006年12月间收治的5例行脾切除治疗原发性骨髓纤维化的病人资料。结果:本组病人均行脾切除术,其中2例加行贲门周围血管离断术.术后发生脾窝积液1例,肺部感染1例。随访3月至5年,病人贫血状况、左上腹疼痛症状均得到缓解.生活质量得到改善。结论:脾切除对有适应证的原发性骨髓纤维化是可行的治疗手段,可明显改善病人的症状,提高生活质量。 相似文献
27.
干燥综合征是一种以口眼干燥为特征,主要累及外分泌腺的弥漫性结缔组织病。其发病可能与病毒感染、遗传和性激素异常等多种因素有关,在这些因素的共同作用下,机体免疫异常,组织损伤。与该病关系较密切的病毒有EB病毒、丙型肝炎病毒、巨细胞病毒、反转录病毒等。病毒在干燥综合征的发病机制中可能起重要的作用。 相似文献
28.
血清α—L-岩藻糖苷酶(AFU)对原发性肝癌(PHC)的诊断意义 总被引:1,自引:0,他引:1
目的研究血清α-L-岩藻糖苷酶(AFU)对原发性肝癌的诊断意义。方法分别测定20例正常对照者、45例慢性乙型肝炎、40例肝硬化、50例转移性肝癌及35例原发性肝癌患者的血清AFU。结果原发性肝癌组的血清AFU浓度和阳性率显著高手其他各组。结论血清AFU对原发性肝癌的诊断有重要价值。 相似文献
29.
Self-expandable metallic stent for unresectable malignant strictures in the esophagus and cardia 总被引:2,自引:0,他引:2
Shigeru Lee Harushi Osugi Taigo Tokuhara Masashi Takemura Masahiro Kaneko Yoshinori Tanaka Yushi Fujiwara Satoshi Nishizawa Hiroshi Iwasaki Shigefumi Suehiro 《The Japanese Journal of Thoracic and Cardiovascular Surgery》2005,53(9):470-476
Objective Self-expandable metallic stent (EMS) placement has been the first choice for dysphagia because of the certainty over its safety,
low invasiveness, and immediate efficacy. However, there still remain some problems in relation to the EMS placement site
and anticancer therapies before and after EMS placement. Methods: Consecutive 78 patients in whom EMS was placed due to the unresectable malignant stricture in the esophagus or cardia from
July 1995 to August 2003 in our department were studied. Results: Gastroesophageal reflux was found in 5 of 8 patients after placement of conventional EMS for the stricture in the gastroesophageal
junction. Meanwhile, acid and bile reflux into the esophagus were not detected by pH and bilirubin monitoring, respectively,
in 6 patients after placement of the EMS with an anti-reflux mechanism for the stricture in the gastroesophageal junction.
The median survival period of all patients after EMS placement was 123 days. The median survival period of 7 patients with
radiotherapy only after EMS placement was 138 days and that of 17 patients with radiotherapy before EMS placement was 60 days,
which was shorter than that of the former (p<0.05). On the other hand, the median survival period after hospital admission
due to dysphagia of these 7 patients was longer than that of 17 patients with radiotherapy only before EMS placement, although,
the difference was not significant. Conclusion: EMS with an antireflux mechanism is not commercially available in Japan and approval is urgently required. The indication
of radiotherapy associated with EMS placement is to be studied further. 相似文献
30.
Saravana V. Karuppiah Keith G. Buchan 《The Japanese Journal of Thoracic and Cardiovascular Surgery》2006,54(9):396-398
A case of primary malignant melanoma in the mediastinum presenting as recurrent laryngeal nerve palsy is reported. Tissue biopsy at mediastinotomy yielded a diagnosis of malignant melanoma. The mass was fixed to the left aspect of the trachea and to the upper border of the left main bronchus and could not be removed surgically. Further extensive clinical and radiological investigations revealed no evidence of tumor elsewhere in the body. 相似文献